Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-19 9:30 pm Purchase |
2025-03-17 | 13D | Dianthus Therapeutics, Inc. DNTH |
Avidity Partners Management LP | 3,378,939 9.900% |
448,689 (+15.31%) |
Filing History |
| 2025-02-14 10:42 am Purchase |
2024-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
Avidity Partners Management LP | 502,600 6.900% |
55 (+0.01%) |
Filing History |
| 2025-02-14 10:26 am Sale |
2024-12-31 | 13G | Perspective Therapeutics, Inc. CATX |
Avidity Partners Management LP | 2,841,024 4.200% |
-749,402 (-20.87%) |
Filing History |
| 2025-02-14 10:21 am Purchase |
2024-12-31 | 13G | SCYNEXIS, Inc. SCYX |
Avidity Partners Management LP | 4,211,870 9.900% |
34,667 (+0.83%) |
Filing History |
| 2025-02-14 10:16 am Purchase |
2024-12-31 | 13G | Immunic, Inc. IMUX |
Avidity Partners Management LP | 9,022,363 9.900% |
32,920 (+0.37%) |
Filing History |
| 2025-02-14 10:10 am Sale |
2024-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Avidity Partners Management LP | 2,048,020 7.600% |
-809,553 (-28.33%) |
Filing History |
| 2025-02-14 10:02 am Unchanged |
2024-12-31 | 13G | Context Therapeutics Inc. CNTX |
Avidity Partners Management LP | 7,776,296 9.900% |
0 (Unchanged) |
Filing History |
| 2024-12-03 9:19 pm Purchase |
2024-11-29 | 13D | Dianthus Therapeutics, Inc. DNTH |
Avidity Partners Management LP | 2,930,250 9.900% |
7,427 (+0.25%) |
Filing History |
| 2024-11-14 7:38 pm Purchase |
2024-09-30 | 13G | Oruka Therapeutics, Inc. ORKA |
Avidity Partners Management LP | 790,926 2.300% |
790,926 (New Position) |
Filing History |
| 2024-11-14 7:07 pm Purchase |
2024-09-30 | 13G | SCYNEXIS, Inc. SCYX |
Avidity Partners Management LP | 4,177,203 9.900% |
71,993 (+1.75%) |
Filing History |
| 2024-11-14 6:14 pm Purchase |
2024-09-30 | 13G | Perspective Therapeutics, Inc. CATX |
Avidity Partners Management LP | 3,590,426 5.300% |
3,590,426 (New Position) |
Filing History |
| 2024-11-14 6:08 pm Sale |
2024-09-30 | 13G | Caribou Biosciences, Inc. CRBU |
Avidity Partners Management LP | 0 0.000% |
-6,360,212 (Position Closed) |
Filing History |
| 2024-11-14 6:01 pm Sale |
2024-09-30 | 13G | Jasper Therapeutics, Inc. JSPR |
Avidity Partners Management LP | 0 0.000% |
-760,000 (Position Closed) |
Filing History |
| 2024-11-14 5:33 pm Purchase |
2024-09-30 | 13G | Immunic, Inc. IMUX |
Avidity Partners Management LP | 8,989,443 9.900% |
90,025 (+1.01%) |
Filing History |
| 2024-11-14 5:31 pm Unchanged |
2024-09-30 | 13G | Context Therapeutics Inc. CNTX |
Avidity Partners Management LP | 7,776,296 9.900% |
0 (Unchanged) |
Filing History |
| 2024-11-14 5:28 pm Purchase |
2024-09-30 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Avidity Partners Management LP | 2,857,573 9.900% |
195,367 (+7.34%) |
Filing History |
| 2024-11-14 4:22 pm Sale |
2024-09-30 | 13G | Karyopharm Therapeutics Inc. KPTI |
Avidity Partners Management LP | 316,071 3.700% |
-429,846 (-57.63%) |
Filing History |
| 2024-05-13 10:37 am Purchase |
2024-05-02 | 13G | Context Therapeutics Inc. CNTX |
Avidity Partners Management LP | 7,776,296 9.900% |
7,776,296 (New Position) |
Filing History |
| 2024-04-09 8:57 pm Purchase |
2024-04-03 | 13G | ARCA biopharma, Inc. ABIO |
Avidity Partners Management LP | 83,333 6.900% |
83,333 (New Position) |
Filing History |
| 2024-03-27 4:26 pm Purchase |
2024-03-18 | 13G | Jasper Therapeutics, Inc. JSPR |
Avidity Partners Management LP | 760,000 5.100% |
760,000 (New Position) |
Filing History |